Claims
- 1. A method of inhibiting the growth of yeasts and moulds comprising contacting a material with an effective amount of a bacterial preparation comprising Lactobacillus casei ssp. rhamnosus LC-705 strain, DSM 7061.
- 2. The method of inhibiting the growth of yeasts and moulds as claimed in claim 1, wherein the bacterial preparation comprising the Lactobacillus casei ssp. rhamnosus LC-705 strain, DSM 7061, is in a cell suspension.
- 3. A method of inhibiting the growth of yeasts and moulds comprising contacting a material with an effective amount of a bacterial preparation comprising Lactobacillus casei ssp. rhamnosus LC-705 strain, DSM 7061, and a bacterium of the genus Propionibacterium.
- 4. The method of inhibiting the growth of yeasts and moulds as claimed in claim 3, wherein the bacterial preparation comprises the Lactobacillus casei ssp. rhamnosus LC-705 strain, DSM 7061, and Propionibacterium shermanii JS, DSM 7067.
- 5. The method of inhibiting the growth of yeasts and moulds as claimed in claim 4, wherein the bacterial preparation is in a cell suspension in fermentation broth.
- 6. A method of inhibiting the growth of yeasts and moulds comprising contacting a material with an effective amount of a bacterial preparation comprising Lactobacillus casei ssp. rhamnosus LC-705 strain, DSM 7061, and another strain of the bacterium Lactobacillus casei.
- 7. A biologically pure culture of Lactobacillus casei ssp. rhamnosus LC-705, DSM 7061 having yeast and mold inhibiting properties.
- 8. A bacterial preparation having yeast and mold inhibiting properties comprising the Lactobacillus casei ssp. rhamnosus LC-705 strain, DSM 706and a carrier.
- 9. The bacterial preparation as claimed in claim 8 comprising the Lactobacillus casei ssp. rhamnosus LC-705 strain, DSM 7061, as a cell suspension in fermentation broth.
- 10. The bacterial preparation as claimed in claim 9 wherein the cell suspension is concentrated.
- 11. The bacterial preparation as claimed in claim 9 wherein the cell suspension is freeze-dried.
- 12. The bacterial preparation as claimed in claim 2 comprising additional conventional agents used for yeast and mould inhibition.
- 13. The bacterial preparation as claimed in claim 12 wherein the additional conventional agents used for mold and yeast inhibition are selected from the group consisting of propionate and phenylalanine.
- 14. A bacterial preparation having yeast and mold inhibiting properties comprising the Lactobacillus casei ssp. rhamnosus LC-705 strain DSM 7061, in combination with a bacterium of the genus Propionibacterium.
- 15. The bacterial preparation as claimed in claim 14 comprising the Lactobacillus casei ssp. rhamnosus LC-705 strain, DSM 7061 together with the Propionibacterium shermanii JS, DSM 7067.
- 16. A bacterial preparation as claimed in claim 15 comprising the Lactobacillus casei ssp. rhamnosus LC-705 strain, DSM 7061, together with the Propionibacterium shermanii JS, DSM 7067, as a cell suspension in fermentation broth.
- 17. A bacterial preparation as claimed in claim 14 comprising additional conventional agents used for yeast and mould inhibition.
- 18. The bacterial preparation as claimed in claim 17 wherein the additional conventional agents used for mold and yeast inhibition are selected from the group consisting of propionate and phenylalanine.
- 19. A bacterial preparation having yeast and mold inhibiting properties comprising the Lactobacillus casei ssp. rhamnosus LC-705 strain, DSM 7061, in combination with another strain of the bacterium Lactobacillus casei.
- 20. A bacterial preparation as claimed in claim 19 comprising the Lactobacillus casei ssp. rhamnosus LC-705 strain, DSM 7061, as a cell suspension in fermentation broth in combination with another strain of the bacterium Lactobacillus casei.
- 21. A bacterial preparation as claimed in claim 19 comprising additionally conventional agents used for yeast and mould inhibition.
- 22. The bacterial preparation as claimed in claim 21 wherein the additional conventional agents used for mold and yeast inhibition are selected from the group consisting of propionate and phenylalanine.
Priority Claims (1)
Number |
Date |
Country |
Kind |
922699 |
Jun 1992 |
FIX |
|
Parent Case Info
This application is a continuation, of application Ser. No. 08/000,608, filed Jan. 5, 1993, now abandoned.
US Referenced Citations (8)
Foreign Referenced Citations (3)
Number |
Date |
Country |
0302300 |
Aug 1989 |
EPX |
0408220A2 |
Jan 1991 |
EPX |
751382 |
Apr 1979 |
SUX |
Non-Patent Literature Citations (1)
Entry |
Merck Index, 10th Edition, 1983, p. 1127, #7726. |
Continuations (1)
|
Number |
Date |
Country |
Parent |
608 |
Jan 1993 |
|